Intrinsiqs

Is Niagen Bioscience Inc overvalued?

Niagen Bioscience Inc (NAGE) — key valuation metrics and fundamentals.

No verdict
Price
$2.98
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$237.3M
Dividend yield
0.0%
Return on equity
20.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NAGE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated